Atea Pharmaceuticals Inc
Biotechnology
Healthcare
AVIR
84.42 M shares
NASDAQ US
traded
25 Jun 2025
listed
no
open
3.37
52 week high
3.82
high
3.51
52 week low
2.55
low
3.35
growth
-10.34 %
previous Close
3.38
P/E ratio
market cap
269 M
div yield
0
usd
Sep 2024
qoq
revenue
0.00 %
net incoming
-31.15 M
23.13 %
eps
0.00 %
22.92 %
eps surprise
24.49 %
net profit margin
-3115100000.00 %
0.00 %
operating incoming
-37.20 M
20.71 %
net change in cash
-144.93 M
-275.71 %
cash on hand
98.46 M
-59.55 %
cost of revenue
0.00 %
top top